Evidence map›Paper›PMID 40641860›Full record

ArticleJournal of clinical medicine research2025

Impact of Chronic Obstructive Pulmonary Disease Burden on Patients With Atrial Fibrillation: A Nationwide Study.

Sherif Eltawansy, Faizan Ahmed, Grishma Sharma, Pawel Lajczak, Ogechukwu Obi, Hardik A Valand, Bhavin Patel, Dawood Shehzad, Mohamed Abugrin, Anam Mubasher and 3 more

Abstract read
In one paragraph

Article in Journal of clinical medicine research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sherif EltawansyInternal Medicine Department, Jersey Shore University Medical Center, Neptune, NJ 08831, USA.
Faizan AhmedDivision of Cardiology, Duke University Hospital, Durham, NC, USA.
Grishma SharmaDepartment Internal Medicine, Kathmandu University School of Medical Sciences, Dhulikhel, Nepal.
Pawel LajczakMedical University of Silesia, 40-055 Katowice, Poland.
Ogechukwu ObiCollege of Osteopathic Medicine, New York Institute of Technology, Westbury, NY, USA.
Hardik A ValandDepartment of Internal Medicine, Allegheny General Hospital, Pittsburgh, PA, USA.
Bhavin PatelDepartment of Internal Medicine, Trinity Health Oakland/Wayne State University, Pontiac, MI, USA.
Dawood ShehzadDepartment of Internal Medicine, University of South Dakota, Sioux Falls, SD, USA.
Mohamed AbugrinDepartment of Internal Medicine, Bassett Medical Center, Cooperstown, NY, USA.
Anam MubasherDepartment of Internal Medicine, Texas Health Resources Bedford/Denton, TX, USA.
Asjad SalmanDepartment of Internal Medicine, Carle Health, Urbana-champaign, IL, USA.
Joseph HeatonDepartment of Internal Medicine, Jersey Shore University Medical Center, Neptune, NJ, USA.
Jesus AlmendralCardiology Department, Jersey Shore University Medical Center, Neptune, NJ, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic obstructive pulmonary disease (COPD) and atrial fibrillation (Afib) are frequently comorbid, with COPD patients exhibiting a higher risk of Afib-related hospitalizations. This study investigated the relationship between COPD and Afib, focusing on 30-day readmission rates and outcomes. Methods: We conducted a retrospective cohort study using the Nationwide Readmissions Database (NRD) from 2016 to 2020. We included adult patients (≥ 18 years) with a primary diagnosis of Afib while excluding those with December discharges to ensure a complete 30-day follow-up. We compared patients with and without COPD, analyzing 30-day readmission rates, length of stay (LOS), hospital costs, in-hospital mortality, and associated factors using multivariable Cox and logistic regression models. Results: A total of 1,064,982 patients admitted with Afib were included, of which 873,070 had no COPD, and 191,912 had it. COPD patients were older (73.19 vs. 70.82 years), had a shorter LOS (coefficient = -0.05, P = 0.002, 95% confidence interval (CI): -0.08 to -0.02), and had a higher comorbidity burden (Elixhauser comorbidity index: 5.13 vs. 3.43, P < 0.0001). The 30-day readmission rate was significantly higher in the COPD group (16.0% vs. 9.0%, P < 0.001). Logistic regression revealed that COPD increased the odds of readmission (odds ratio: 1.35, 95% CI: 1.32 to 1.39, P < 0.001). Conclusion: COPD is a significant risk factor for 30-day readmission and in-hospital mortality among Afib patients, underscoring the need for integrated approaches targeting both diseases.

Indexed as

Atrial fibrillationChronic obstructive pulmonary diseaseHospital mortalityPatient readmissionRisk factors

Identifiers

PMID40641860
PMCPMC12239842

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.